. . "BOTTLE of 30 TABLETS NDC:50436-3996-4 in a BOTTLE of 120 TABLETS 17 PATIENT COUNSELING INFORMATION See FDA-approved patient labeling (Medication Guide). 17.1 Rash Prior to initiation of treatment with Lamotrigine, the patient should be instructed that a rash or other signs or symptoms of hypersensitivity (e.g., fever, lymphadenopathy) may herald a serious medical event and that the patient should" . . .